ÂÜÀòÂÒÂ×

The Clinical Development Team at Axcella is responsible for overseeing the design and execution of clinical trials to evaluate the safety and efficacy of the company's novel metabolic modulator compositions. This team, led by senior experts including the Chief Medical Officer, collaborates closely with cross-functional departments to ensure that clinical programs align with regulatory standards, optimize patient enrollment, and achieve key milestones in the drug development process. Their goal is to advance innovative treatments for metabolic dysregulation while ensuring a robust and ethical testing environment.